Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com

StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Pulmatrix Stock Down 5.0 %

Pulmatrix stock opened at $5.91 on Wednesday. The firm has a 50-day moving average price of $3.28 and a two-hundred day moving average price of $2.48. The firm has a market capitalization of $21.58 million, a price-to-earnings ratio of -2.36 and a beta of 1.54. Pulmatrix has a 52-week low of $1.55 and a 52-week high of $8.44.

Pulmatrix Company Profile

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.